These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37041106)

  • 61. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Asian venous thromboembolism guidelines: prevention of venous thromboembolism.
    Liew NC; Chang YH; Choi G; Chu PH; Gao X; Gibbs H; Ho CO; Ibrahim H; Kim TK; Kritpracha B; Lee LH; Lee L; Lee WY; Li YJ; Nicolaides AN; Oh D; Pratama D; Ramakrishnan N; Robless PA; Villarama-Alemany G; Wong R;
    Int Angiol; 2012 Dec; 31(6):501-16. PubMed ID: 23222928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
    Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
    Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events.
    Zeidan AM; Streiff MB; Lau BD; Ahmed SR; Kraus PS; Hobson DB; Carolan H; Lambrianidi C; Horn PB; Shermock KM; Tinoco G; Siddiqui S; Haut ER
    Am J Hematol; 2013 Jul; 88(7):545-9. PubMed ID: 23553743
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 66. When is It Safe to Start VTE Prophylaxis After Blunt Solid Organ Injury? A Prospective Study from a Level I Trauma Center.
    Schellenberg M; Inaba K; Biswas S; Heindel P; Benjamin E; Strumwasser A; Matsushima K; Lam L; Demetriades D
    World J Surg; 2019 Nov; 43(11):2797-2803. PubMed ID: 31367780
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multidisciplinary Bundle Approach in Venous Thromboembolism Prophylaxis in Patients with Non-Traumatic Subarachnoid Hemorrhage.
    Phan B; Fagaragan L; Alaraj A; Kim KS
    Clin Appl Thromb Hemost; 2022; 28():10760296221074682. PubMed ID: 35068226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors.
    Mei R; Wang G; Chen R; Wang H
    World J Surg Oncol; 2022 Sep; 20(1):245. PubMed ID: 36058927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
    Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU.
    Ryskamp RP; Trottier SJ
    Chest; 1998 Jan; 113(1):162-4. PubMed ID: 9440584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Venous thromboembolism prophylaxis in the pediatric trauma population.
    Thompson AJ; McSwain SD; Webb SA; Stroud MA; Streck CJ
    J Pediatr Surg; 2013 Jun; 48(6):1413-21. PubMed ID: 23845640
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modification of the National Inpatient Medication Chart improves venous thromboembolism prophylaxis rates in high-risk medical patients.
    Yates M; Reddy M; Machumpurath B; Phelps G; Hampson SA
    Intern Med J; 2014 Feb; 44(2):190-4. PubMed ID: 24528815
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Venous thromboembolic events in critically ill traumatic brain injury patients.
    Skrifvars MB; Bailey M; Presneill J; French C; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
    Intensive Care Med; 2017 Mar; 43(3):419-428. PubMed ID: 28028552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial.
    Jung YJ; Seo HS; Park CH; Jeon HM; Kim JI; Yim HW; Song KY
    JAMA Surg; 2018 Oct; 153(10):939-946. PubMed ID: 30027281
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of timing of initiation of pharmacologic venous thromboembolism prophylaxis with outcomes in trauma patients.
    Hecht JP; Han EJ; Cain-Nielsen AH; Scott JW; Hemmila MR; Wahl WL
    J Trauma Acute Care Surg; 2021 Jan; 90(1):54-63. PubMed ID: 32890341
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
    Samuel S; Li W; Dunn K; Cortes J; Nguyen T; Moussa D; Kumar A; Dao T; Beeson J; Choi HA; McCullough LD
    J Thromb Thrombolysis; 2023 May; 55(4):617-625. PubMed ID: 37029256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.